ANLBIO

About:

ANLBIO is a researcher and developer of adeno-associated virus-based gene therapy products.

Website: http://anlbio.com

Top Investors: BNK Venture Capital, POSCO CAPITAL, Hyundai Technology Investment, Friend Investment Partners

Description:

Total Funding Amount:

12.5B KRW

Headquarters Location:

Seongnam, Kyonggi-do, South Korea

Founded Date:

2019-01-01

Contact Email:

anlbio(AT)anlbio.com

Founders:

Hong Sung Moon

Number of Employees:

Last Funding Date:

2022-02-17

IPO Status:

Private

Industries: